INS and diabetes mellitus: Out of 380 DM patients, 153 patients (40.3%) were treated with diet only, 87 patients (22.9%) with MET, 67 patients (17.6%) with sulfonylurea (SU) derivatives, 108 patients (28.4%) with insulin, 26 patients (6.8%) with DPPIV-inhibitors, 3 patients (0.8%) with repaglinide and 1 patient (0.3%) was treated with liraglutide.